EUVIMEDEUVIMED entdecken
Editorial

Protection against Alzheimer’s Disease with APOE Christchurch Variant — How?

John Hardy

New England Journal of Medicine · 20.06.2024 · 390 (23) · 2212-2213

DOI: 10.1056/nejme2403712 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 20.06.2024. Verfasst von John Hardy. Beteiligte Einrichtung: From the U.K. Dementia Research Institute and the Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London. Hauptthemen laut MEDLINE: Apolipoprotein E2, Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protective variants of genetic loci are of particular interest for two reasons: first, because they are important from a clinical genetic perspective; and second, because they may give mechanistic clues about potential therapeutic strategies. In Alzheimer’s disease, the most prevalent protective allele is APOE2 (encoding apolipoprotein E2), which has a population allele frequency of approximately 10%. 1 With regard to the age at onset, sporadic Alzheimer’s disease is delayed by approximately 10 years in persons with APOE2 homozygosity as compared with the general population. 2-4 APOE2 heterozygosity delays the onset of sporadic Alzheimer’s disease by approximately 5 years (relative to APOE3 homozygosity) . . .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein E2Alzheimer DiseaseAge of OnsetSouth American PeopleHumansApolipoproteins EFamilyMiddle Aged

Substanzen

Apolipoproteins EApolipoprotein E2

Autor:innen und Institutionen

  • From the U.K. Dementia Research Institute and the Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London.

Zitieren

APA

Hardy, J. (2024). Protection against Alzheimer’s Disease with APOE Christchurch Variant — How?. New England Journal of Medicine, 390(23), 2212-2213. https://doi.org/10.1056/nejme2403712

Vancouver

Hardy J. Protection against Alzheimer’s Disease with APOE Christchurch Variant — How?. New England Journal of Medicine. 2024;390(23):2212-2213. doi:10.1056/nejme2403712

BibTeX
@article{Hardy2024,
  author = {Hardy, John},
  title = {Protection against Alzheimer’s Disease with APOE Christchurch Variant — How?},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {23},
  pages = {2212--2213},
  doi = {10.1056/nejme2403712}
}
Kostenlos starten →